MedTrace Logo

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors

NCT02647021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-01-03

No results posted yet for this study

Summary

The investigators will conduct a randomized controlled trial examining 12-week, 24-week and one year outcomes from a combined therapeutic and physical exercise program that aims to bridge head-and-neck cancer survivors from acute care rehabilitation services to community-based exercise programming.

Conditions

  • Head and Neck Neoplasms
  • Accessory Nerve Injury
  • Fatigue

Interventions

BEHAVIORAL

Therapeutic Exercise

A specialized therapeutic exercise program to address neck and shoulder dysfunction due to spinal accessory nerve damage.

BEHAVIORAL

Therapeutic + Lower Body Exercise

A combined therapeutic exercise program (as per the comparison arm) plus the addition of lower body resistance exercise

Sponsors & Collaborators

  • Cross Cancer Institute

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Margaret L. McNeely, PhD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-03-15
Completion
2020-03-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647021 on ClinicalTrials.gov